Richard Schlegel

Millennium Engineering and Integration (United States)

Papers

1

Total Citations

31

H-Index

1

About

Richard Schlegel is a pioneering virologist and cell biologist whose research has fundamentally advanced our understanding of human papillomavirus (HPV) biology and its role in carcinogenesis. His work centers on the molecular mechanisms by which HPV oncoproteins E6 and E7 drive cellular immortalization and transformation, particularly in cervical keratinocytes. Schlegel’s major contributions include elucidating how HPV E6 and E7 proteins modulate key cellular pathways, such as the upregulation of insulin-like growth factor-binding protein 3 (IGFBP-3), a finding that linked viral oncogenesis to growth factor signaling. His landmark 2002 study on IGFBP-3 expression during HPV-induced immortalization, cited 31 times, provided critical insights into the early stages of cervical cancer development. Beyond this, Schlegel’s research has explored viral entry mechanisms and vaccine development, influencing both basic science and clinical applications. His work has been widely recognized for its impact on cancer biology, with cumulative citations reflecting his role in shaping HPV research. For students and researchers, Schlegel’s career exemplifies how dissecting viral-host interactions can reveal fundamental principles of cell growth control and inform strategies for cancer prevention.

Research Focus

Key Achievements

1
H-Index
1
Papers
31
Total Citations
31
Avg Citations/Paper
🏆 Most Cited Paper
Insulin-Like Growth Factor-Binding Protein 3 Expression Increases during Immortalization of Cervical Keratinocytes by Human Papillomavirus Type 16 E6 and E7 Proteins
31 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Millennium Engineering and Integration (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago